Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
01/07/1999 | CA2294473A1 Novel family of pheromone receptors |
01/07/1999 | CA2292379A1 Member of the tnf family useful for treatment and diagnosis of disease |
01/06/1999 | CN1204369A Multi-functional hematopoietic receptor agonists |
01/06/1999 | CN1203948A Promoter of human endoglin gene and its use |
01/06/1999 | CN1203946A Industrial production process of velvet deerhorn cell |
01/05/1999 | US5856463 PSKH-1 ribozymes |
01/05/1999 | US5856448 Materials involved in the control of the cardiovascular system, and in particular to activities mediated by thrombin and its cellular receptor. |
01/05/1999 | US5856447 Vaccine against lyme disease |
01/05/1999 | US5856435 Gene therapy; transferring nucleic acids |
01/05/1999 | US5856297 Human C3b/C4b receptor (CR1) |
01/05/1999 | US5856201 Methods of detection using a cellulose binding domain fusion product |
01/05/1999 | US5856187 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
01/05/1999 | US5856186 Co-cultivating bone marrow and osteoblast cells |
01/05/1999 | US5856185 Method for making reflection defective retroviral vectors for infecting human cells |
01/05/1999 | US5856184 Isolated domains of type IV collagen to modify cell and tissue interactions |
01/05/1999 | US5856180 Immortalization of dendritic cells with V-MYC oncogene |
01/05/1999 | US5856179 Polypeptide production in animal cell culture |
01/05/1999 | US5856171 Cell death regulators |
01/05/1999 | US5856162 Receptor-type phosphotyrosine phosphatase-κ |
01/05/1999 | US5856152 Transgenic supplying to cells |
01/05/1999 | US5856151 Antifungal preparations containing osmotin |
01/05/1999 | US5856136 Human stem cell antigens |
01/05/1999 | US5856129 Hydridized detector |
01/05/1999 | US5856124 DNA encoding high-affinity melatonin receptors |
01/05/1999 | US5856112 Method for selectively inducing biomarker expression in urologic tumor tissue for diagnosis and treatment thereof |
01/05/1999 | US5856098 Detection of this receptor variant in cells of obese individuals, and methods for treating obesity by targeting variant. |
01/05/1999 | US5856091 Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 |
01/05/1999 | US5855891 Ichimeric papillomavirus-like particles |
01/05/1999 | US5855886 Immunoassay method involving fewer, preferably only one, reaction steps than conventional immunoassay in a therapeutic application, two prodrugs may be released which only become active for treatment when both are present. |
01/05/1999 | US5855608 For facilitating healing of voids in tissue |
01/03/1999 | CA2236462A1 Murc |
01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
01/01/1999 | CA2236452A1 Gida1 |
01/01/1999 | CA2236441A1 Gida2 |
01/01/1999 | CA2236435A1 Gida2 |
01/01/1999 | CA2236425A1 Gida1 |
01/01/1999 | CA2235785A1 Serine/threonine protein kinase (h-sgk2) |
12/30/1998 | WO1998059246A1 C-peptide specific assay procedure |
12/30/1998 | WO1998059063A2 Bovine adenovirus type 3 genome |
12/30/1998 | WO1998059062A1 Specific gene activation by chimeric gal4 transcription factors in stable transgenic plants |
12/30/1998 | WO1998059061A1 Male tissue-preferred regulatory region and method of using same |
12/30/1998 | WO1998059059A1 Expression system for production of therapeutic proteins |
12/30/1998 | WO1998059058A2 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
12/30/1998 | WO1998059049A1 Reagents and methods useful for detecting diseases of the breast |
12/30/1998 | WO1998059039A1 Receptor kinase, bin1 |
12/30/1998 | WO1998059038A1 Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
12/30/1998 | WO1998059037A1 D-amino acid oxidase promoter from t. variabilis |
12/30/1998 | WO1998059035A2 Serum-free cell growth medium |
12/30/1998 | WO1998058967A1 Self-assembling peptide surfaces for cell patterning and interactions |
12/30/1998 | WO1998058963A1 Method for producing polyclonal and monoclonal antibodies |
12/30/1998 | WO1998058957A2 Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
12/30/1998 | WO1998058954A2 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens |
12/30/1998 | WO1998058952A1 Angiotensin derivatives |
12/30/1998 | WO1998058951A1 Isolated nona- and decapeptides which bind to hla molecules, and the use thereof |
12/30/1998 | WO1998058945A1 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor |
12/30/1998 | WO1998058944A1 Compositions and methods for activating genes of interest |
12/30/1998 | WO1998040404A3 Secreted proteins and polynucleotides encoding them |
12/30/1998 | EP0887419A2 Methods for producing taxane-type diterpenes |
12/30/1998 | EP0887416A2 Human AFC1 |
12/30/1998 | EP0887415A2 Human RCE1 |
12/30/1998 | EP0887413A2 Histidine kinase |
12/30/1998 | EP0887411A2 N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Streptococcus pneumoniae |
12/30/1998 | EP0887410A2 DNA encoding a plasminogen activating protein |
12/30/1998 | EP0887408A1 Wnt-3 oncogene: polypeptides and polynucleotides |
12/30/1998 | EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor |
12/30/1998 | EP0887406A2 A member of the FRZB family, franzzled |
12/30/1998 | EP0886651A1 Persephin and related growth factors |
12/30/1998 | EP0886650A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions |
12/30/1998 | EP0886646A1 Novel compounds |
12/30/1998 | EP0886644A1 Long wavelength engineered fluorescent proteins |
12/30/1998 | EP0886643A1 Human g-protein chemokine receptor hsatu68 |
12/30/1998 | EP0700443B1 Sialidase-deficient cells |
12/30/1998 | EP0689589B1 Oxidatively stable alpha-amylase |
12/30/1998 | EP0661999B1 Anti-feline immunodeficiency virus (fiv) vaccines |
12/30/1998 | EP0633945B1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN |
12/30/1998 | EP0573606B1 A native-state histoculturing method for skin |
12/30/1998 | EP0553244B1 Targeted immunostimulation with bispecific reagents |
12/30/1998 | CN1203633A Diagnosis of susceptibility to cancer and treatment thereof |
12/30/1998 | CN1203632A P16 expression constructs and their application in cancer therapy |
12/30/1998 | CN1203631A Constructs and methods for enhancing protein levels in photosynthetic organisms |
12/30/1998 | CN1203531A Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (GDNF) protein product |
12/30/1998 | CN1203275A Processes for preparation of Marek's disease virus using continuous mammalian cell lines |
12/30/1998 | CN1203238A Novel insulin derivatives having rapid onset of action |
12/30/1998 | CA2594375A1 Bovine adenovirus type 3 genome |
12/30/1998 | CA2296002A1 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens |
12/30/1998 | CA2295200A1 Receptor kinase, bin1 |
12/30/1998 | CA2294468A1 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor |
12/30/1998 | CA2294257A1 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
12/30/1998 | CA2294195A1 Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
12/30/1998 | CA2294119A1 Expression system for production of therapeutic proteins |
12/30/1998 | CA2293833A1 Compositions and methods for activating genes of interest |
12/30/1998 | CA2293661A1 Reagents and methods useful for detecting diseases of the breast |
12/30/1998 | CA2292844A1 D-amino acid oxidase promoter from t. variabilis |
12/29/1998 | US5854411 Human chloride channel |
12/29/1998 | US5854400 Monoclonal antibodies which neutralize HIV-1 infection |
12/29/1998 | US5854392 β APP-C100 receptor |
12/29/1998 | US5854224 Composition and method for delivery of nucleic acids |
12/29/1998 | US5854220 Glial mitogenic factors, their preparation and use |
12/29/1998 | US5854207 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
12/29/1998 | US5854203 Tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 |